Table 1

Demographics and clinical and laboratory findings in gout patients and controls

DataPatients with goutAll controlsPatients with RAPatients with SpAHealthy controlsp Value
Age (years), mean (SD) (range)56.4 (11.5) (26–81)56.6 (13.5) (34–84)61.8 (12) (47–84)49.5 (9.9) (37–66)56.3 (15.4) (34–77)0.079
BMI (kg/m2), mean (SD) (range)29 (3.8) (20.3–44)27.2 (3.4) (20–34)25.8 (3.2) (20–31.8)28.6 (3.7) (21.6–34)27.6 (3) (22.2–32.5)0.006*
Uricaemia (mg/dl), mean (SD) (range)8 (1.9) (3.6–12.5)5.5 (1.1) (2.3–7.6)5.5 (1.3) (2.3–7.4)6 (0.9) (4.7–7.6)5.2 (1.0) (3.2–7.5)<0.0005**
Cholesterolaemia (mg/dl), mean (SD) (range)199.2 (38) (108–313)201.8 (36.7) (134–296)200 (30.2) (151–253)212.7 (39.3) (172–296)196.5 (42) (134–267)0.730
Triglyceridaemia (mg/dl), mean (SD) (range)169.1 (98) (42–542)156.2 (137.7) (39–839)140.1 (45.8) (69–204)207.3 (248.8) (55–839)138.3 (91.8) (39–371)0.371
Glycaemia (mg/dl), mean (SD) (range)104.4 (22.8) (78–238)102 (23) (71–196)103.9 (19.1) (80–155)107.9 (32.4) (82–196)95.9 (19.5) (71–152)0.544
CRP (mg/litre), mean (SD) (range)5.2 (7.7) (0–42)5.9 (7.5) (0–29)8.4 (8.2) (0.1–29)6.7 (8.3) (0.4–22)1.6 (3.4) (0–11.8)0.134
ESR (mm/h), mean (SD) (range)11.5 (10.7) (0–61)15.8 (16.8) (1–78)25.8 (17.2) (12–78)10.5 (16) (2–58)5.7 (4.6) (1–14)0.002***
  • *Tukey's test found significant differences (p<0.05) between patients with gout and those with RA.

  • **Tukey's test found significant differences (p<0.05) between patients with gout and the control groups.

  • ***Tukey's test found significant differences (p<0.05) between patients with RA and the other groups.

  • BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis; SpA, spondyloarthritis.